For: |
Li MR, Zhang SH, Chao K, Liao XH, Yao JY, Chen MH, Zhong BH. |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v20/i38/14010.htm |
Number | Citing Articles |
1 |
Yongjie Qi, Chen Chen, Xuejun Li, Yi Liu, Huiqin Qi, Yingchang Xue, Fengyong Yang. Silencing ApoC3 alleviates LPS-induced acute lung injury by inhibiting TLR signaling pathway. Immunologic Research 2023; 71(5): 687 doi: 10.1007/s12026-023-09379-z
|
2 |
Rui-Nan Zhang, Rui-Dan Zheng, Yu-Qiang Mi, Da Zhou, Feng Shen, Guang-Yu Chen, Chan-Yan Zhu, Qin Pan, Jian-Gao Fan. APOC3 rs2070666 Is Associated with the Hepatic Steatosis Independently of PNPLA3 rs738409 in Chinese Han Patients with Nonalcoholic Fatty Liver Diseases. Digestive Diseases and Sciences 2016; 61(8): 2284 doi: 10.1007/s10620-016-4120-7
|
3 |
Sara Saki, Nader Saki, Hossein Poustchi, Reza Malekzadeh. Assessment of Genetic Aspects of Non-alcoholic Fatty Liver and Premature Cardiovascular Events. Middle East Journal of Digestive Diseases 2020; 12(2): 65 doi: 10.34172/mejdd.2020.166
|
4 |
David Aguilar-Recarte, Xavier Palomer, Manuel Vázquez-Carrera. Uncovering the role of apolipoprotein C-III in insulin resistance. Clínica e Investigación en Arteriosclerosis 2021; 33(2): 108 doi: 10.1016/j.arteri.2020.09.003
|
5 |
Yan Jiang, Junpeng Ma, Hao Li, Yi Liu, Chao You. Effect of apolipoprotein C3 genetic polymorphisms on serum lipid levels and the risk of intracerebral hemorrhage. Lipids in Health and Disease 2015; 14(1) doi: 10.1186/s12944-015-0047-9
|
6 |
Daniela Carmen Oniciu, Taishi Hashiguchi, Yuichiro Shibazaki, Charles L. Bisgaier, Pavel Strnad. Gemcabene downregulates inflammatory, lipid-altering and cell-signaling genes in the STAM™ model of NASH. PLOS ONE 2018; 13(5): e0194568 doi: 10.1371/journal.pone.0194568
|
7 |
Wei-Kei Wong, Wah-Kheong Chan. Nonalcoholic Fatty Liver Disease: A Global Perspective. Clinical Therapeutics 2021; 43(3): 473 doi: 10.1016/j.clinthera.2021.01.007
|
8 |
Bing-Feng Chen, Yeuh Chien, Pin-Hsing Tsai, Pang-Chung Perng, Yi-Ping Yang, Kuan-Chun Hsueh, Chia-Hung Liu, Yuan-Hung Wang. A PRISMA-compliant meta-analysis of apolipoprotein C3 polymorphisms and nonalcoholic fatty liver disease. Journal of the Chinese Medical Association 2021; 84(10): 923 doi: 10.1097/JCMA.0000000000000564
|
9 |
Eliza Christopoulou, Vasilios Tsimihodimos, Theodosios Filippatos, Moses Elisaf. Apolipoprotein CIII and diabetes. Is there a link?. Diabetes/Metabolism Research and Reviews 2019; 35(3) doi: 10.1002/dmrr.3118
|
10 |
Fabio Salvatore Macaluso, Marcello Maida, Salvatore Petta. Genetic background in nonalcoholic fatty liver disease: A comprehensive review. World Journal of Gastroenterology 2015; 21(39): 11088-11111 doi: 10.3748/wjg.v21.i39.11088
|
11 |
Soo Lim, Marja‐Riitta Taskinen, Jan Borén. Crosstalk between nonalcoholic fatty liver disease and cardiometabolic syndrome. Obesity Reviews 2019; 20(4): 599 doi: 10.1111/obr.12820
|
12 |
Karina Sato-Espinoza, Perapa Chotiprasidhi, Mariella R Huaman, Javier Díaz-Ferrer. Update in lean metabolic dysfunction-associated steatotic liver disease. World Journal of Hepatology 2024; 16(3): 452-464 doi: 10.4254/wjh.v16.i3.452
|
13 |
Joost Willebrords, Isabel Veloso Alves Pereira, Michaël Maes, Sara Crespo Yanguas, Isabelle Colle, Bert Van Den Bossche, Tereza Cristina Da Silva, Cláudia Pinto Marques Souza de Oliveira, Wellington Andraus, Venâncio Avancini Alves, Bruno Cogliati, Mathieu Vinken. Strategies, models and biomarkers in experimental non-alcoholic fatty liver disease research. Progress in Lipid Research 2015; 59: 106 doi: 10.1016/j.plipres.2015.05.002
|
14 |
David Aguilar-Recarte, Xavier Palomer, Manuel Vázquez-Carrera. Uncovering the role of apolipoprotein C-III in insulin resistance. Clínica e Investigación en Arteriosclerosis (English Edition) 2021; 33(2): 108 doi: 10.1016/j.artere.2021.04.002
|
15 |
Xiangyu Hu, Xiaoqin Jia, Cong Xu, Yingying Wei, Zhengbing Wang, George Liu, Qiang You, Guotao Lu, Weijuan Gong. Downregulation of NK cell activities in Apolipoprotein C-III-induced hyperlipidemia resulting from lipid-induced metabolic reprogramming and crosstalk with lipid-laden dendritic cells. Metabolism 2021; 120: 154800 doi: 10.1016/j.metabol.2021.154800
|
16 |
Aalam Sohal, Hunza Chaudhry, Kris V. Kowdley. Genetic Markers Predisposing to Nonalcoholic Steatohepatitis. Clinics in Liver Disease 2023; 27(2): 333 doi: 10.1016/j.cld.2023.01.006
|
17 |
Giuseppina Umano, Mariangela Martino, Nicola Santoro. The Association between Pediatric NAFLD and Common Genetic Variants. Children 2017; 4(6): 49 doi: 10.3390/children4060049
|
18 |
Xiao-Lin Li, Jian-Qing Sui, Lin-Lin Lu, Nan-Nan Zhang, Xin Xu, Quan-Yong Dong, Yong-Ning Xin, Shi-Ying Xuan. Gene polymorphisms associated with non-alcoholic fatty liver disease and coronary artery disease: a concise review. Lipids in Health and Disease 2016; 15(1) doi: 10.1186/s12944-016-0221-8
|
19 |
Xiaoqing Huang, Wenfan Chen, Changsheng Yan, Renzhi Yang, Qiongyun Chen, Hongzhi Xu, Yuanpeng Huang. Gypenosides improve the intestinal microbiota of non-alcoholic fatty liver in mice and alleviate its progression. Biomedicine & Pharmacotherapy 2019; 118: 109258 doi: 10.1016/j.biopha.2019.109258
|
20 |
Jing-Lu Jin, Yuan-Lin Guo, Jian-Jun Li. Apoprotein C-III: A review of its clinical implications. Clinica Chimica Acta 2016; 460: 50 doi: 10.1016/j.cca.2016.06.016
|
21 |
Kanuengnit Choochuay, Punna Kunhapan, Apichaya Puangpetch, Sissades Tongsima, Pornpen Srisawasdi, Abhasnee Sobhonslidsuk, Somnuek Sungkanuparph, Mohitosh Biswas, Chonlaphat Sukasem. Associations of <i>PNPLA3</i> and <i>LEP</i> genetic polymorphisms with metabolic-associated fatty liver disease in Thai people living with human immunodeficiency virus. World Journal of Hepatology 2024; 16(3): 366-378 doi: 10.4254/wjh.v16.i3.366
Abstract(200) |
Core Tip(173) |
Full Article(HTML)(1049)
|
Full Article with Cover (PDF)-1132K(43)
|
Audio-999K(0)
|
Peer-Review Report-181K(25)
|
Answering Reviewers-121K(25)
|
Supplementary Material-86K(26)
|
Full Article (PDF)-571K(61)
|
Full Article (XML)-169K(27)
|
Times Cited (0)
|
Total Visits (3316)
|
Open
|
22 |
Alexander J. Kovalic, Pratik Banerjee, Quynh T. Tran, Ashwani K. Singal, Sanjaya K. Satapathy. Genetic and Epigenetic Culprits in the Pathogenesis of Nonalcoholic Fatty Liver Disease. Journal of Clinical and Experimental Hepatology 2018; 8(4): 390 doi: 10.1016/j.jceh.2018.04.001
|
23 |
Barbora Nováková, Radan Brůha. Serum markers in diagnostics of steatohepatitis. Vnitřní lékařství 2019; 65(9): 577 doi: 10.36290/vnl.2019.099
|
24 |
Fan Yuan, Zhan Gu, Yan Bi, Ruixue Yuan, Weibo Niu, Decheng Ren, Lei Zhang, Guang He, Bao-Cheng Liu. The association between rs1260326 with the risk of NAFLD and the mediation effect of triglyceride on NAFLD in the elderly Chinese Han population. Aging 2022; 14(6): 2736 doi: 10.18632/aging.203970
|
25 |
Magdy M. Youssef, Amal Elshaer, Rizk Elbaz, Yehia A. Ellazek, Ahmad El-Waseef, Ahmad Settin. ApolipoproteinC3 Gene Variants in Nonalcoholic Fatty Liver Disease in Egypt. American Journal of Biochemistry and Molecular Biology 2017; 8(1): 16 doi: 10.3923/ajbmb.2018.16.22
|
26 |
Huanhuan Yang, Guochong Chen, Chunli Song, Deming Li, Qinghua Ma, Guangliang Chen, Xinli Li. A novel index including SNPs for the screening of nonalcoholic fatty liver disease among elder Chinese. Medicine 2018; 97(13): e0272 doi: 10.1097/MD.0000000000010272
|
27 |
Qing-Yang Xu, Han Li, Hai-Xia Cao, Qin Pan, Jian-Gao Fan, Zhanjun Jia. APOC3 rs2070667 Associates with Serum Triglyceride Profile and Hepatic Inflammation in Nonalcoholic Fatty Liver Disease. BioMed Research International 2020; 2020: 1 doi: 10.1155/2020/8869674
|
28 |
Ingrid Rivera‐Íñiguez, Karina González‐Becerra, Omar Ramos‐Lopez, Yolanda E. Peréz‐Beltrán, Marian S. Chagüén‐Hernández, Erika Martínez‐López, Edgar J. Mendivil. Lipid‐Related Genetic Variants for Personalized Dietary Interventions: A Systematic Review. Molecular Nutrition & Food Research 2023; 67(14) doi: 10.1002/mnfr.202200675
|